Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Short Interest Update

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the target of a large decrease in short interest in February. As of February 28th, there was short interest totalling 30,200 shares, a decrease of 25.6% from the February 13th total of 40,600 shares. Based on an average daily volume of 765,800 shares, the short-interest ratio is currently 0.0 days.

Ono Pharmaceutical Stock Up 0.0 %

OTCMKTS:OPHLY opened at $3.68 on Tuesday. The business’s 50-day moving average price is $3.46 and its two-hundred day moving average price is $3.87. Ono Pharmaceutical has a twelve month low of $3.21 and a twelve month high of $5.67.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.